Brady Corporation (BRC)

Elevation Oncology Revenue

Brady had revenue of $382.59M in the quarter ending April 30, 2025, with 11.42% growth. This brings the company's revenue in the last twelve months to $1.46B, up 8.62% year-over-year. In the fiscal year ending July 31, 2024, Brady had annual revenue of $1.34B with 0.72% growth.

• Revenue (ttm): $1.46B
• Revenue Growth: +8.62%
• P/S Ratio: 2.30
• Revenue / Employee: $256,093
• Employees: 5,700
• Market Cap: 3.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jul 31, 2024	1.34B	9.53M	0.72%
Jul 31, 2023	1.33B	29.80M	2.29%
Jul 31, 2022	1.30B	157.36M	13.75%
Jul 31, 2021	1.14B	63.40M	5.86%
Jul 31, 2020	1.08B	-79.35M	-6.84%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.